UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Decreased by Kayne Anderson Rudnick Investment Management LLC

Kayne Anderson Rudnick Investment Management LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 22.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 55,257 shares of the healthcare conglomerate’s stock after selling 15,876 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC’s holdings in UnitedHealth Group were worth $28,140,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of UNH. Aveo Capital Partners LLC grew its position in shares of UnitedHealth Group by 23.8% during the 4th quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock valued at $1,139,000 after buying an additional 416 shares during the last quarter. 9258 Wealth Management LLC raised its position in shares of UnitedHealth Group by 7.3% during the 4th quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock worth $2,250,000 after purchasing an additional 290 shares during the period. Gryphon Financial Partners LLC grew its stake in UnitedHealth Group by 80.9% during the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock worth $3,275,000 after buying an additional 2,782 shares during the last quarter. TrinityPoint Wealth LLC lifted its stake in UnitedHealth Group by 102.8% in the fourth quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the healthcare conglomerate’s stock valued at $7,778,000 after buying an additional 7,489 shares during the last quarter. Finally, ProVise Management Group LLC grew its position in shares of UnitedHealth Group by 3.0% during the fourth quarter. ProVise Management Group LLC now owns 5,256 shares of the healthcare conglomerate’s stock worth $2,767,000 after acquiring an additional 155 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In related news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

UNH opened at $575.00 on Friday. The firm has a market capitalization of $529.22 billion, a P/E ratio of 35.15, a PEG ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock has a fifty day moving average of $577.10 and a 200-day moving average of $520.80.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same period in the prior year, the firm earned $6.14 earnings per share. The firm’s revenue was up 6.4% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. Morgan Stanley upped their target price on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Barclays raised their target price on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Wells Fargo & Company increased their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. TD Cowen increased their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Finally, Argus upped their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.